Cargando…

Identification of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients Implanted With a Continuous-Flow Left Ventricular Assist Device

Heart failure affects over 5 million people in the United States. Its rising prevalence and the limited supply of donor hearts is increasing the use of mechanical cardiac support with the implantation of continuous-flow ventricular assist devices (CF-VAD). Patients with CF-VAD implants are at risk o...

Descripción completa

Detalles Bibliográficos
Autores principales:	McClane, Nathan, Jeske, Walter, Walenga, Jeanine M., Escalante, Vicki, Hoppensteadt, Debra, Schwartz, Jeffrey, Bakhos, Mamdouh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714718/ https://www.ncbi.nlm.nih.gov/pubmed/29552914 http://dx.doi.org/10.1177/1076029618760235

Ejemplares similares

Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist Devices
por: Walenga, Jeanine M., et al.
Publicado: (2020)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism
por: Darwish, Iman, et al.
Publicado: (2022)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

Hemostatic complications associated with ventricular assist devices
por: Hilal, Talal, et al.
Publicado: (2019)

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
por: O’Hara, Alexander, et al.
Publicado: (2023)

Ventricular perforation by pacemaker lead repaired with two hemostatic devices
por: Prestipino, Filippo, et al.
Publicado: (2014)

Outcomes of continuous flow left ventricular assist device after surgical left ventricular restoration
por: Gyoten, Takayuki, et al.
Publicado: (2023)

Using More Than 1 (Path)Way to Kill a Host Cell: Lessons From Clostridium perfringens Enterotoxin
por: McClane, Bruce, et al.
Publicado: (2020)

Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes
por: Prechel, Margaret, et al.
Publicado: (2018)

Continuous flow left ventricular assist devices and gastrointestinal bleeding
por: Turner, Katja R
Publicado: (2012)

A Novel Small Acid Soluble Protein Variant Is Important for Spore Resistance of Most Clostridium perfringens Food Poisoning Isolates
por: Li, Jihong, et al.
Publicado: (2008)

Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges
por: Gao, Zhijian, et al.
Publicado: (2012)

Human Claudin-8 and -14 Are Receptors Capable of Conveying the Cytotoxic Effects of Clostridium perfringens Enterotoxin
por: Shrestha, Archana, et al.
Publicado: (2013)

Evidence That VirS Is a Receptor for the Signaling Peptide of the Clostridium perfringens Agr-like Quorum Sensing System
por: Li, Jihong, et al.
Publicado: (2020)

NanH Is Produced by Sporulating Cultures of Clostridium perfringens Type F Food Poisoning Strains and Enhances the Cytotoxicity of C. perfringens Enterotoxin
por: Li, Jihong, et al.
Publicado: (2021)

Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
por: Pausch, Jonas, et al.
Publicado: (2023)

Efficacy of the hemostatic device VasoSTAT and the study of hemostatic factor
por: Naganawa, Hirokazu, et al.
Publicado: (2021)

Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support
por: Critsinelis, Andre, et al.
Publicado: (2018)

Continuous‐flow left ventricular assist devices: Management in the emergency department
por: Hockstein, Maxwell A.
Publicado: (2020)

Endocrine Challenges in Patients with Continuous-Flow Left Ventricular Assist Devices
por: Martucci, Gennaro, et al.
Publicado: (2021)

Gastrointestinal bleeding on continuous‐flow left ventricular assist device therapy
por: Hammer, Yoav, et al.
Publicado: (2023)

Hemostatic devices in abdominal surgery
por: Di Capua, F, et al.
Publicado: (2011)

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmia in Continuous-Flow Left Ventricular Assist Device
por: Vlismas, Peter P., et al.
Publicado: (2021)

Late Complications Following Continuous-Flow Left Ventricular Assist Device Implantation
por: Grimm, Joshua C., et al.
Publicado: (2015)

Exercise gas exchange in continuous-flow left ventricular assist device recipients
por: Mezzani, Alessandro, et al.
Publicado: (2018)

Prevalence of Cerebral Microbleeds in Patients With Continuous‐Flow Left Ventricular Assist Devices
por: Yoshioka, Daisuke, et al.
Publicado: (2017)

Metabolic Dysfunction in Continuous‐Flow Left Ventricular Assist Devices Patients and Outcomes
por: Nguyen, Ann B., et al.
Publicado: (2019)

Pulmonary vasodilator use in continuous-flow left ventricular assist device management
por: Pirlamarla, Preethi, et al.
Publicado: (2021)

Enterotoxigenic Clostridium perfringens: Detection and Identification
por: Miyamoto, Kazuaki, et al.
Publicado: (2012)

Left ventricular noncompaction as diagnosed by established cardiac magnetic resonance imaging criteria is not associated with increased adverse events compared to non-ischemic dilated cardiomyopathy
por: Memon, Shermeen B, et al.
Publicado: (2015)

Can We Improve on the Rapid Assessment of Clinically Relevant Levels of Direct Acting Oral Anticoagulants (DOAC)?
por: Walenga, Jeanine M.
Publicado: (2022)

Accuracy of Doppler blood pressure measurement in continuous‐flow left ventricular assist device patients
por: Li, Song, et al.
Publicado: (2019)

Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS/VirR Two-Component Regulatory System
por: Chen, Jianming, et al.
Publicado: (2011)

Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications
por: Freedman, John C., et al.
Publicado: (2016)

Correction for Chen et al., Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS/VirR Two-Component Regulatory System
por: Chen, Jianming, et al.
Publicado: (2015)

Clostridium perfringens Sialidases: Potential Contributors to Intestinal Pathogenesis and Therapeutic Targets
por: Li, Jihong, et al.
Publicado: (2016)

RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin
por: Shrestha, Archana, et al.
Publicado: (2019)

Retraction for Chen et al., “Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS/VirR Two-Component Regulatory System”
por: Chen, Jianming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j22bfeffpbedl14pvj7h1qa2o5